AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
Characterization of disseminated tumor cells
Authors: Hosch, SB Braun, S Pantel, K
Citation: Sb. Hosch et al., Characterization of disseminated tumor cells, SEM SURG ON, 20(4), 2001, pp. 265-271
Occult micrometastasis: enrichment, identification and characterization ofsingle disseminated tumour cells
Authors: Pantel, K Otte, M
Citation: K. Pantel et M. Otte, Occult micrometastasis: enrichment, identification and characterization ofsingle disseminated tumour cells, SEM CANC B, 11(5), 2001, pp. 327-337
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
Authors: Braun, S Schindlbeck, C Hepp, F Janni, W Kentenich, C Reithmuller, G Pantel, K
Citation: S. Braun et al., Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse, J CL ONCOL, 19(2), 2001, pp. 368-375
Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? - Reply
Authors: Braun, S Harbeck, N Pantel, K
Citation: S. Braun et al., Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? - Reply, J CL ONCOL, 19(15), 2001, pp. 3590-3592
Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity
Authors: Maletz, K Kufer, P Mack, M Raum, T Pantel, K Riethmuller, G Gruber, R
Citation: K. Maletz et al., Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity, INT J CANC, 93(3), 2001, pp. 409-416
erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients
Authors: Braun, S Schlimok, G Heumos, I Schaller, G Riethdorf, L Riethmuller, C Pantel, K
Citation: S. Braun et al., erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients, CANCER RES, 61(5), 2001, pp. 1890-1895
MAGE-A gene expression pattern in primary breast cancer
Authors: Otte, M Zafrakas, M Riethdorf, L Pichlmeier, U Loning, T Janicke, F Pantel, K
Citation: M. Otte et al., MAGE-A gene expression pattern in primary breast cancer, CANCER RES, 61(18), 2001, pp. 6682-6687
The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence
Authors: Janni, W Hepp, F Rjosk, D Kentenich, C Strobl, B Schindlbeck, C Hantschmann, P Sommer, H Pantel, K Braun, S
Citation: W. Janni et al., The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence, CANCER, 92(1), 2001, pp. 46-53
Diagnostic and clinical impact of disseminated tumour cells in bone marrow
Authors: Braun, S Pantel, K
Citation: S. Braun et K. Pantel, Diagnostic and clinical impact of disseminated tumour cells in bone marrow, DEUT MED WO, 125(41), 2000, pp. 1237-1239
Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
Authors: Zippelius, A Lutterbuse, R Riethmuller, G Pantel, K
Citation: A. Zippelius et al., Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells, CLIN CANC R, 6(7), 2000, pp. 2741-2750
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
Authors: Passlick, B Sienel, W Seen-Hibler, R Wockel, W Thetter, O Mutschler, W Pantel, K
Citation: B. Passlick et al., Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer, CLIN CANC R, 6(10), 2000, pp. 3944-3948
Detection and clinical relevance of micrometastatic cancer cells
Authors: Pantel, K Doeberitz, MV
Citation: K. Pantel et Mv. Doeberitz, Detection and clinical relevance of micrometastatic cancer cells, CURR OPIN O, 12(1), 2000, pp. 95-101
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
Authors: Braun, S Kentenich, C Janni, W Hepp, F de Waal, J Willgeroth, F Sommer, H Pantel, K
Citation: S. Braun et al., Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients, J CL ONCOL, 18(1), 2000, pp. 80-86
Identification and characterisation of minimal residual disease in solid tumors
Authors: Pantel, K Otte, M
Citation: K. Pantel et M. Otte, Identification and characterisation of minimal residual disease in solid tumors, ACT MED AUS, 27, 2000, pp. 8-12
Bone marrow metastases in breast cancer - Reply
Authors: Braun, S Schlimok, G Pantel, K
Citation: S. Braun et al., Bone marrow metastases in breast cancer - Reply, N ENG J MED, 343(8), 2000, pp. 578-578
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Authors: Braun, S Pantel, K Muller, P Janni, W Hepp, F Kentenich, CRM Gastroph, S Wischnik, A Dimpfl, T Kindermann, G Riethmuller, G Schlimok, G
Citation: S. Braun et al., Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer., N ENG J MED, 342(8), 2000, pp. 525-533
The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells
Authors: Passlick, B Sienel, W Seen-Hibler, R Wockel, W Thetter, O Pantel, K
Citation: B. Passlick et al., The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells, INT J CANC, 87(4), 2000, pp. 548-552
Malignant potential and cytogenetic characteristics of occult disseminatedtumor cells in esophageal cancer
Authors: Hosch, S Kraus, J Scheunemann, P Izbicki, JR Schneider, C Schumacher, U Witter, K Speicher, MR Pantel, K
Citation: S. Hosch et al., Malignant potential and cytogenetic characteristics of occult disseminatedtumor cells in esophageal cancer, CANCER RES, 60(24), 2000, pp. 6836-6840
In vitro differentiation of endothelial cells from AC133-positive progenitor cells
Authors: Gehling, UM Ergun, S Schumacher, U Wagener, C Pantel, K Otte, M Schuch, G Schafhausen, P Mende, T Kilic, N Kluge, K Schafer, B Hossfeld, DK Fiedler, W
Citation: Um. Gehling et al., In vitro differentiation of endothelial cells from AC133-positive progenitor cells, BLOOD, 95(10), 2000, pp. 3106-3112
Detection and clinical importance of micrometastatic disease
Authors: Pantel, K Cote, RJ Fodstad, O
Citation: K. Pantel et al., Detection and clinical importance of micrometastatic disease, J NAT CANC, 91(13), 1999, pp. 1113-1124
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Authors: Borgen, E Naume, B Nesland, JM Kvalheim, G Beiske, K Fodstad, O Diel, I Solomayer, EF Theocharous, P Coombes, RC Smith, BM Wunder, E Marolleau, JP Garcia, J Pantel, K
Citation: E. Borgen et al., Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells, CYTOTHERAPY, 1(5), 1999, pp. 377-388
Biological relevance of occult tumor cells in a lymph node of a patient with resectable esophageal cancer
Authors: Scheunemann, P Hosch, SB Witter, K Kraus, J Speicher, MR Pantel, K Izbicki, JR
Citation: P. Scheunemann et al., Biological relevance of occult tumor cells in a lymph node of a patient with resectable esophageal cancer, LANG ARCH S, 1999, pp. 105-108
Plakoglobin downregulation as an indicator of an unfavourable prognosis inesophageal cancer
Authors: Hosch, SB Stoecklein, N Pichlmeier, U Pantel, K Izbicki, JR
Citation: Sb. Hosch et al., Plakoglobin downregulation as an indicator of an unfavourable prognosis inesophageal cancer, LANG ARCH S, 1999, pp. 123-125
Micrometastatic bone marrow involvement: detection and prognostic significance
Authors: Braun, S Pantel, K
Citation: S. Braun et K. Pantel, Micrometastatic bone marrow involvement: detection and prognostic significance, MED ONCOL, 16(3), 1999, pp. 154-165
Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow
Authors: Braun, S Hepp, F Kentenich, CRM Janni, W Pantel, K Riethmuller, G Willgeroth, F Sommer, HL
Citation: S. Braun et al., Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow, CLIN CANC R, 5(12), 1999, pp. 3999-4004
Risultati: 1-25 | 26-41